BYRNE JOSEPH A. enters CEN BIOTECH INC with 1.53M shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Indirect Derivatives
Filed: 6/3/2021ACC: 0001437749-21-014028
DirectorOfficer· Chief Executive Officer
Since Jul 2017
1.53M
Baseline shares
89% direct
1.36M
Direct ownership
1 position
76.12K
Derivative underlying
1 instrument
2
Security positions
164K indirect
Non-Derivative Holdings2
Common Stock
IndirectShares owned164K
Common Stock
DirectShares owned1.36M
Total
1.36M direct·164K indirect1.53M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 164K | Indirect |
| Common Stock | 1.36M | Direct |
| Total | 1.53M | 1.36M direct·164K indirect |
Derivative Holdings1
Common Stock
DirectUnderlying security
Common Stock
Underlying shares
76.12K
Shares owned
N/A
Exercise price
1.6000
Expiration
—
Exercise window
—
Total
Underlying
76.12K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Common Stock Direct | Common Stock | 1.6000 | — | — | 76.12K | N/A |
| Total | 76.12K | 0.00 | ||||